NEW YORK, June 20, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. (“Travere”) (NASDAQ: TVTX) concerning possible violations of federal securities laws. The investigation focuses on whether Travere issued false…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.